Medtronic Plc Stock Fundamentals
| 2M6 Stock | EUR 82.19 0.46 0.56% |
Medtronic PLC fundamentals help investors to digest information that contributes to Medtronic PLC's financial success or failures. It also enables traders to predict the movement of Medtronic Stock. The fundamental analysis module provides a way to measure Medtronic PLC's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medtronic PLC stock.
Medtronic |
Medtronic PLC Company Current Valuation Analysis
Medtronic PLC's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Medtronic PLC Current Valuation | 113.84 B |
Most of Medtronic PLC's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medtronic PLC is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Medtronic PLC has a Current Valuation of 113.84 B. This is much higher than that of the Healthcare sector and significantly higher than that of the Medical Devices industry. The current valuation for all Germany stocks is significantly lower than that of the firm.
Medtronic PLC Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Medtronic PLC's current stock value. Our valuation model uses many indicators to compare Medtronic PLC value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medtronic PLC competition to find correlations between indicators driving Medtronic PLC's intrinsic value. More Info.Medtronic PLC is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.57 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Medtronic PLC is roughly 1.75 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Medtronic PLC's earnings, one of the primary drivers of an investment's value.Medtronic Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medtronic PLC's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Medtronic PLC could also be used in its relative valuation, which is a method of valuing Medtronic PLC by comparing valuation metrics of similar companies.Medtronic PLC is currently under evaluation in current valuation category among its peers.
Medtronic Fundamentals
| Return On Equity | 0.0784 | |||
| Return On Asset | 0.0449 | |||
| Profit Margin | 0.13 % | |||
| Operating Margin | 0.22 % | |||
| Current Valuation | 113.84 B | |||
| Shares Outstanding | 1.33 B | |||
| Shares Owned By Insiders | 0.09 % | |||
| Shares Owned By Institutions | 84.51 % | |||
| Price To Earning | 26.98 X | |||
| Price To Book | 1.99 X | |||
| Price To Sales | 3.15 X | |||
| Revenue | 31.69 B | |||
| Gross Profit | 21.71 B | |||
| EBITDA | 8.78 B | |||
| Net Income | 5.04 B | |||
| Cash And Equivalents | 9.85 B | |||
| Cash Per Share | 7.35 X | |||
| Total Debt | 20.37 B | |||
| Debt To Equity | 50.40 % | |||
| Current Ratio | 2.59 X | |||
| Book Value Per Share | 38.67 X | |||
| Cash Flow From Operations | 7.35 B | |||
| Earnings Per Share | 2.89 X | |||
| Price To Earnings To Growth | 3.00 X | |||
| Target Price | 145.56 | |||
| Number Of Employees | 95 K | |||
| Beta | 0.73 | |||
| Market Capitalization | 103.37 B | |||
| Total Asset | 90.98 B | |||
| Z Score | 3.0 | |||
| Annual Yield | 0.03 % | |||
| Five Year Return | 1.80 % | |||
| Net Asset | 90.98 B | |||
| Last Dividend Paid | 2.67 |
About Medtronic PLC Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Medtronic PLC's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medtronic PLC using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medtronic PLC based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. The company was founded in 1949 and is headquartered in Dublin, Ireland. MEDTRONIC PLC operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 101013 people.
Currently Active Assets on Macroaxis
Additional Information and Resources on Investing in Medtronic Stock
When determining whether Medtronic PLC is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Medtronic Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Medtronic Plc Stock. Highlighted below are key reports to facilitate an investment decision about Medtronic Plc Stock:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Medtronic PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For more detail on how to invest in Medtronic Stock please use our How to Invest in Medtronic PLC guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.